PMID: 9736303Sep 15, 1998

Influence of ketanserin on experimental loss of renal blood flow autoregulation

Kidney International. Supplement
M VerbekeN H Lameire

Abstract

Serotonin is important for effective renal blood flow (RBF) autoregulation in the normal rat and at two or seven days of reperfusion following renal ischemia. It has been suggested that after these reperfusion periods and during renal perfusion pressure (RPP) lowering, the vasodilatory autoregulation mechanism is not damaged but overwhelmed by increased 5-HT2-mediated vasoconstriction, resulting in complete loss of autoregulation. This study analyzes the influence of the 5-HT2-antagonist ketanserin on RBF autoregulation after two hours or one day of renal reperfusion following ischemia and in a model of cyclosporine (20 mg/kg.day for 10 days)-induced nephrotoxicity. Autoregulation was lost both after brief reperfusion periods and after cyclosporine. Similar to the two or seven days of reperfusion experiments, ketanserin in the cyclosporine model led to reappearance of autoregulation down to RPP 95 mm Hg. Despite an increased response to intrarenal serotonin after two hours of reperfusion, autoregulation was not restored by ketanserin. At one day of reperfusion and with ketanserin, autoregulation was present down to 105 mm Hg. Thus, during the early reflow period, other factors (of decreasing importance) most likely add to autor...Continue Reading

References

Mar 1, 1992·Kidney International·V M Dixit
Jun 1, 1991·Kidney International·J D CongerW S Hammond
Nov 1, 1990·Kidney International·N H LameireM A Waterloos
Jan 1, 1985·Journal of Cardiovascular Pharmacology·J H MyersR C Webb
May 1, 1989·Kidney International·M SteinhausenD L Wiegman
May 1, 1983·Kidney International·E MatthysJ H Stein
Oct 15, 1994·Thrombosis Research·D UedaK Kawabe
Jan 1, 1995·Nephron·I DarlametsosN Papanikolaou
Feb 1, 1993·Kidney International·K EndlichM Steinhausen
May 1, 1993·Kidney International·J V Bonventre

Citations

Jun 26, 2009·Vascular Health and Risk Management·Nader Nouri-MajalanHosein Moshtaghian
Feb 6, 2004·Best Practice & Research. Clinical Anaesthesiology·N H Lameire, Raymond Vanholder
Mar 24, 2018·Critical Care : the Official Journal of the Critical Care Forum·Emiel Hendrik Post, Jean-Louis Vincent
Oct 22, 2009·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Ahmad OryanAllen E Goodship

Related Concepts

Metazoa
Antihypertensive Agents
R-41,468
Renal Blood Flow
Rats, Laboratory

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.